Adipocyte‐Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer

Advanced Science - Tập 9 Số 28 - 2022
Qiumo Zhang1, Ting Deng1, Hongdian Zhang1, Duo Zuo1, Qihang Zhu1, Ming Bai1, Rui Liu1, Tao Ning1, Le Zhang1, Zhentao Yu2,1, Haiyang Zhang1, Yi Ba1
1Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China
2Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518172 China

Tóm tắt

AbstractObesity is closely related to a poor prognosis in patients with advanced colorectal cancer (CRC), but the mechanisms remain unclear. Ferroptosis is a form of nonapoptotic cell death characterized by lipid reactive oxygen species (ROS) accumulation and iron dependency and is associated with the chemoresistance of tumors. Here, it is shown that adipose‐derived exosomes reduce ferroptosis susceptibility in CRC, thus promoting chemoresistance to oxaliplatin. It is found that microsomal triglyceride transfer protein (MTTP) expression is increased in the plasma exosomes of CRC patients with a high body fat ratio, serving as an inhibitor of ferroptosis and reducing sensitivity to chemotherapy. Mechanistically, the MTTP/proline‐rich acidic protein 1 (PRAP1) complex inhibited zinc finger E‐box binding homeobox 1 expression and upregulated glutathione peroxidase 4 and xCT, leading to a decreased polyunsaturated fatty acids ratio and lipid ROS levels. Moreover, experiments are carried out in organoids, and a tumor implantation model is established in obese mice, demonstrating that the inhibition of MTTP increases the sensitivity to chemotherapy. The results reveal a novel intracellular signaling pathway mediated by adipose‐derived exosomes and suggest that treatments targeting secreted MTTP might reverse oxaliplatin resistance in CRC.

Từ khóa


Tài liệu tham khảo

10.3322/caac.21565

10.3322/caac.21660

10.1200/JCO.2008.20.6771

10.1200/JCO.2006.08.2974

10.1002/advs.201903233

10.1038/sj.onc.1206933

10.1200/JCO.2012.48.4691

10.1111/j.1467-789X.2009.00613.x

10.1371/journal.pone.0053916

10.1001/jamaoncol.2016.0732

10.3389/fendo.2018.00758

10.1016/j.cell.2017.09.021

10.1016/j.cell.2012.03.042

10.1186/s12943-020-01168-8

10.1016/j.freeradbiomed.2018.09.014

10.1016/j.cell.2013.12.010

10.1038/ncb3064

10.3389/fphar.2018.01371

10.1186/s40880-018-0288-x

10.1007/s13238-020-00789-5

10.1126/science.aaw9872

10.1158/0008-5472.CAN-18-3037

10.1016/j.ejps.2020.105450

10.1080/23723556.2018.1536845

10.1038/s41556-019-0305-6

10.1038/nchembio.2239

10.1038/nchembio.2238

10.1073/pnas.1603244113

10.1016/j.bbrc.2016.08.124

10.1042/bj1180233

10.1016/0009-3084(85)90068-4

10.1074/jbc.RA120.015002

10.1016/j.jcmgh.2020.06.011

10.1038/nature24297

10.1038/nature23007

10.3389/fmolb.2020.00036

10.1016/j.stem.2016.04.003

10.1056/NEJMoa021423

10.1200/JCO.2016.66.8699

10.1200/JCO.2003.05.044

10.1093/ajcn/72.3.694

10.1007/s00109-016-1446-8

10.1016/j.phrs.2015.06.013

10.1016/j.cmet.2017.10.013

10.1038/s41580-020-00324-8

10.7554/eLife.02523

10.1016/j.cmet.2008.07.005

10.1016/j.cmet.2008.08.004

10.1038/cr.2016.95

10.1016/S0021-9258(18)90593-4

10.7554/eLife.03346

10.1080/15384101.2015.1006048

10.1136/gutjnl-2018-317294

10.1016/j.redox.2020.101697

10.1001/jamaoncol.2016.0843

10.1038/s41591-018-0221-5

10.1146/annurev-med-121211-091527

10.7326/0003-4819-120-1-199401010-00004

10.1016/j.ccell.2019.04.002

10.1002/adma.201904197

10.4143/crt.2016.572

10.1002/hep.28574

10.1038/s41418-019-0299-4

10.1016/j.canlet.2015.07.031

10.1038/nature14344

10.7150/thno.14848

10.1038/s41467-020-19193-y

10.1158/2159-8290.CD-19-0338

10.1126/sciadv.aay9789

10.1200/JCO.2017.76.0355

10.1038/s41388-020-1184-9

10.1002/hep.28251

10.2174/0929867328666201217105529